Novartis South Africa is pleased to announce the introduction of Galvus®Met effective from 17 October 2012. This is in addition to the Galvus® range, enhancing their metabolic portfolio.

Here are the Galvus®Met options: Galvus Met 50mg/850mg tablets in 30’s and 60’s Galvus Met 50mg/1000mg tablets in 30’s and 60’s